Rajesh Kumar
Stock Analyst at HSBC
(2.90)
# 1,499
Out of 5,116 analysts
29
Total ratings
57.89%
Success rate
7.76%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Downgrades: Reduce | $144 → $143 | $177.08 | -19.25% | 1 | Dec 10, 2025 | |
| ABBV AbbVie | Upgrades: Buy | $225 → $265 | $229.98 | +15.23% | 5 | Dec 10, 2025 | |
| NVO Novo Nordisk | Downgrades: Hold | n/a | $52.40 | - | 3 | Nov 24, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $235 | $226.92 | +3.56% | 2 | Oct 9, 2025 | |
| LLY Eli Lilly and Company | Upgrades: Hold | $675 → $700 | $1,077.75 | -35.05% | 3 | Aug 27, 2025 | |
| KDP Keurig Dr Pepper | Upgrades: Buy | $36 → $42 | $28.10 | +49.47% | 1 | Apr 25, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $660 → $670 | $580.74 | +15.37% | 3 | Apr 30, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $230.32 | +21.57% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $331.83 | +38.63% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $13 | $31.89 | -59.23% | 1 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $55 → $53 | $54.64 | -3.00% | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Reduce | $97 | $31.20 | +210.90% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $94.52 | +31.19% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $25.09 | +99.28% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $123 | $106.78 | +15.19% | 1 | Jul 14, 2023 |
Biogen
Dec 10, 2025
Downgrades: Reduce
Price Target: $144 → $143
Current: $177.08
Upside: -19.25%
AbbVie
Dec 10, 2025
Upgrades: Buy
Price Target: $225 → $265
Current: $229.98
Upside: +15.23%
Novo Nordisk
Nov 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $52.40
Upside: -
IQVIA Holdings
Oct 9, 2025
Upgrades: Buy
Price Target: $195 → $235
Current: $226.92
Upside: +3.56%
Eli Lilly and Company
Aug 27, 2025
Upgrades: Hold
Price Target: $675 → $700
Current: $1,077.75
Upside: -35.05%
Keurig Dr Pepper
Apr 25, 2025
Upgrades: Buy
Price Target: $36 → $42
Current: $28.10
Upside: +49.47%
Thermo Fisher Scientific
Apr 30, 2024
Maintains: Buy
Price Target: $660 → $670
Current: $580.74
Upside: +15.37%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $230.32
Upside: +21.57%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $331.83
Upside: +38.63%
Teva Pharmaceutical Industries
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $31.89
Upside: -59.23%
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $54.64
Upside: -3.00%
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $31.20
Upside: +210.90%
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $94.52
Upside: +31.19%
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $25.09
Upside: +99.28%
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $106.78
Upside: +15.19%